In addition, in xenograft models of pancreatic cancer, EGR2 gene silencing enhanced the anti-tumor potency of exhausted NK cells, leading to augmented tumor control, reduced tumor growth, decreased PD-1 expression, and the restoration of the cytotoxic potential of exhausted NK cells. The gene discussed is EGR2; the disease is pancreatic neoplasm.